Healthy Skepticism Library item: 15515

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Anderson T.
Novartis under fire for accepting new reward for old drug
The Lancet 2009 Apr 25; 373:(9673):1414
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2960804-7/fulltext

Abstract:

Swiss drug firm Novartis has been accused of abusing an award system designed to encourage innovation for diseases that mainly affect developing countries. Tatum Anderson reports.
A prize, worth up to US$100 million, has been awarded to Novartis for developing a drug that mainly benefits patients in developing countries. The award was issued by the US Food and Drug Administration (FDA) on April 8 and was the first ever award under a new system to provide pharmaceutical companies with the financia …